Financials data is unavailable for this security.
View more
Year on year Dr Hoenle AG had revenues fall -8.40% from 116.09m to 106.34m, though the company grew net income from a loss of 13.36m to a smaller loss of 11.01m.
| Gross margin | 60.59% |
|---|---|
| Net profit margin | -5.40% |
| Operating margin | -2.75% |
| Return on assets | -3.07% |
|---|---|
| Return on equity | -5.57% |
| Return on investment | -3.74% |
More ▼
Cash flow in EURView more
In 2023, Dr Hoenle AG increased its cash reserves by 30.65%, or 2.19m. The company earned 3.14m from its operations for a Cash Flow Margin of 2.96%. In addition the company generated 2.65m cash from investing, though they paid out 3.42m more in financing than they received.
| Cash flow per share | 0.6812 |
|---|---|
| Price/Cash flow per share | 13.13 |
| Book value per share | 15.43 |
|---|---|
| Tangible book value per share | 12.17 |
More ▼
Balance sheet in EURView more
| Current ratio | 1.98 |
|---|---|
| Quick ratio | 0.8544 |
| Total debt/total equity | 0.591 |
|---|---|
| Total debt/total capital | 0.3713 |
More ▼
Growth rates in EUR
SmartText is unavailable
| Div yield(5 year avg) | 0.84% |
|---|---|
| Div growth rate (5 year) | -- |
| Payout ratio (TTM) | -- |
| EPS growth(5 years) | -- |
|---|---|
| EPS (TTM) vs TTM 1 year ago | 48.68 |
More ▼
